WhiteOak Capital Pharma and Healthcare Fund holds 59 instruments (94.48% equity), led by Sun Pharmaceutical Industries Limited (8.53%), Torrent Pharmaceuticals Limited (7.81%) and Laurus Labs Limited (4.94%), as of its 31 July 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of WhiteOak Capital Pharma and Healthcare Fund, managed by WhiteOak Capital Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 59 instruments with an equity allocation of 94.48%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
WhiteOak Capital Pharma and Healthcare Fund's top 10 holdings account for 46.39% of its portfolio, more diversified than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 89.32% of net assets, spread across 3 sectors in total. Since its 30 June 2026 disclosure, the fund added 5 new positions and exited 6 positions, with Divi's Laboratories Limited seeing the largest move (+2.18pp to 3.86%).
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Divi's Laboratories Limited | 1.68% → 3.86% | ▲ +2.18 |
| Zydus Lifesciences Limited | 2.21% → 2.94% | ▲ +0.73 |
| Dr. Lal Path Labs Ltd. | 1.94% → 2.53% | ▲ +0.59 |
| Cipla Limited | 3.25% → 3.72% | ▲ +0.47 |
| Neuland Laboratories Limited | 2.47% → 2.87% | ▲ +0.4 |
| Procter & Gamble Health Limited | 1.31% → 1.7% | ▲ +0.39 |
| Laurus Labs Limited | 4.61% → 4.94% | ▲ +0.33 |
| Anthem Biosciences Limited | 1.14% → 1.47% | ▲ +0.33 |
| Tatva Chintan Pharma Chem Limited | 0.18% → 0.47% | ▲ +0.29 |
| Navin Fluorine International Limited | 1.23% → 1.46% | ▲ +0.23 |
| Stock | Weight | Change |
|---|---|---|
| Fortis Healthcare Limited | 3.62% → 2.2% | ▼ -1.42 |
| Gland Pharma Limited | 1.98% → 0.91% | ▼ -1.07 |
| Krishna Institute of Medical Sciences Limited | 3.3% → 2.34% | ▼ -0.96 |
| Acutaas Chemicals Limited | 2.38% → 1.44% | ▼ -0.94 |
| Max Healthcare Institute Limited | 4.3% → 3.76% | ▼ -0.54 |
| Aurobindo Pharma Limited | 2.69% → 2.42% | ▼ -0.27 |
| Granules India Limited | 1.82% → 1.56% | ▼ -0.26 |
| Supriya Lifescience Limited | 0.78% → 0.6% | ▼ -0.18 |
| Sudeep Pharma Limited | 0.51% → 0.37% | ▼ -0.14 |
| Sun Pharmaceutical Industries Limited | 8.66% → 8.53% | ▼ -0.13 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: WhiteOak Capital Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.